Atlas Trials

Endometrial Endometrioid Adenocarcinoma

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Endometrial Endometrioid Adenocarcinoma

RecordFirmDate
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma (NCT05112601)National Cancer Institute (NCI)2022-06-02
[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer (NCT04972682)Moscow City Oncology Hospital No. 622021-07-01
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer (NCT04214067)National Cancer Institute (NCI)2020-04-09
Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas (NCT03677024)Fudan University2020-02-06
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (NCT03914612)National Cancer Institute (NCI)2019-08-22
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer (NCT04049227)Northwestern University2019-08-12
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer (NCT03422198)University of Utah2018-02-02
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer (NCT02728258)NRG Oncology2016-09-16
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers (NCT02020707)Mayo Clinic2014-02-24
Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer (NCT00478426)National Cancer Institute (NCI)2007-04-30

Track Endometrial Endometrioid Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.